USPTO trademark

IMARVIE

RegisteredUSPTOWord markClass 5

"IMARVIE" is a word mark owned by Glaxo Group Limited, filed at the USPTO on July 16, 2021. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
IMARVIE trademark as filed
As filed with the USPTO
Status
Registered
Since June 28, 2022
Filed
July 16, 2021
Registered
June 28, 2022
Expires
Not recorded
Application no.
90833165
Registration no.
6774663
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns IMARVIE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GlaxoSmithKline

Goods and services

What the mark covers

The products and services IMARVIE is filed for, grouped by Nice class.

  • Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Applicant/correspondence changes (non-responsive) entered
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Teas change of owner address received

9 earlier steps on the official record.

FAQ

About IMARVIE

Who owns the trademark "IMARVIE"?

The USPTO trademark "IMARVIE" (application 90833165) is owned by Glaxo Group Limited.

What is the status of "IMARVIE"?

Its status at the USPTO is: registered.

When was "IMARVIE" registered?

It was registered on June 28, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IMARVIE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d85-38d6-7649-b71c-c7069a81c254
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d85-38d6-7649-b71c-c7069a81c254",
  "object": "trademark",
  "mark_text": "IMARVIE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90833165",
  "filing_date": "2021-07-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}